↓ Skip to main content

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System

Overview of attention for article published in Frontiers in oncology, January 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
13 Mendeley